Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations

Published:2017-06 Issue: Volume:57 Page:58-66
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Mislang Anna Rachelle,Wildes Tanya M.,Kanesvaran Ravindran,Baldini Capucine,Holmes Holly M.,Nightingale Ginah,Coolbrandt Annemarie,Biganzoli Laura

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference84 articles.

1. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents;Bedell;Clin J Oncol Nurs,2003

2. NCCN Task Force Report: oral chemotherapy;Weingart;J Natl Compr Canc Netw,2008

3. Adherence to therapy with oral antineoplastic agents;Partridge;J Natl Cancer Inst,2002

4. Oral chemotherapeutic agents: understanding mechanisms of action and drug interactions;Goodin;Am J Health Syst Pharm,2007

5. Patient preferences for oral vs intravenous palliative chemotherapy;Liu;J Clin Oncol: Off J Am Soc Clin Oncol,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A structured oral chemotherapy teaching tool to improve adherence in adults with multiple myeloma: A pilot randomized controlled trial;Journal of Geriatric Oncology;2024-04

2. Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence Program;Journal of the National Comprehensive Cancer Network;2024-04

3. Disparities in care of older adults of color with cancer: A narrative review;Cancer Medicine;2024-01-17

4. Propuesta de protocolo de dispensación activa de antineoplásicos orales para pacientes de novo en un servicio de farmacia hospitalaria;Pharmaceutical Care España;2023-10-15

5. Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice;Drugs - Real World Outcomes;2023-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3